Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1963 Nov;86(5):1041–1051. doi: 10.1128/jb.86.5.1041-1051.1963

EXPERIMENTAL VIABLE VACCINE AGAINST PULMONARY COCCIDIOIDOMYCOSIS IN MONKEYS1

John L Converse a, Merida W Castleberry a,2, Ernest M Snyder a
PMCID: PMC278564  PMID: 14080770

Abstract

Converse, John L. (U.S. Army Biological Laboratories, Fort Detrick, Frederick, Md.), Merida W. Castleberry, and Ernest M. Snyder. Experimental viable vaccine against pulmonary coccidioidomycosis in monkeys. J. Bacteriol. 86:1041–1051. 1963.—Monkeys (Macaca mulatta) vaccinated by subcutaneous injection in the forearm with from 10 to 108 viable Coccidioides immitis arthrospores were protected against respiratory challenge with approximately 7000 viable arthrospores administered 6 months after vaccination. Protection was evident from: the healthy appearance throughout 4 months after respiratory challenge; negative chest X rays at 15, 30, 60, and 120 days; and only very minor histopathological pulmonary changes on autopsy at 120 days, with negative lung cultures in 80% of the animals. This was in striking contrast to the outward clinical appearance of control monkeys that were unvaccinated or had received nonviable arthrospore vaccines. These monkeys showed severe disease (loss of weight, accelerated respiration, severe coughing, general debilitation), positive X rays, massive pulmonary destruction, positive lung cultures, and death of five of nine animals. The appearance of spherules (very few in number, accompanied by very minor pathological changes) in the lungs of some of the “dissemination controls” (subcutaneous viable vaccination without respiratory challenge) indicated possible dissemination from the primary cutaneous infection, although oral transmission from the cutaneous lesions could not be ruled out.

Full text

PDF
1041

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERMAN R. J., FRIEDMAN L., ROESSLER W. G., SMITH C. E. The virulence and infectivity of twenty-seven strains of Coccidioides immitis. Am J Hyg. 1956 Sep;64(2):198–210. doi: 10.1093/oxfordjournals.aje.a119834. [DOI] [PubMed] [Google Scholar]
  2. BLUNDELL G. P., CASTLEBERRY M. W., LOWE E. P., CONVERSE J. L. The pathology of Coccidioides immitis in the Macaca mulatta. Am J Pathol. 1961 Nov;39:613–630. [PMC free article] [PubMed] [Google Scholar]
  3. CONVERSE J. L., CASTLEBERRY M. W., BESEMER A. R., SNYDER E. M. Immunization of mice against coccidioidomycosis. J Bacteriol. 1962 Jul;84:46–52. doi: 10.1128/jb.84.1.46-52.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. PAPPAGIANIS D., MILLER R. L., SMITH C. E., KOBAYASHI G. S. Response of monkeys to respiratory challenge following subcutaneous inoculation with Coccidioides immitis. Am Rev Respir Dis. 1960 Aug;82:244–250. doi: 10.1164/arrd.1960.82.2.244. [DOI] [PubMed] [Google Scholar]
  5. PAPPAGIANIS D., SMITH C. E., BERMAN R. J., KOBAYASHI G. S. Experimental subcutaneous coccidioidal infection in the mouse. J Invest Dermatol. 1959 May;32(5):589–598. doi: 10.1038/jid.1959.98. [DOI] [PubMed] [Google Scholar]
  6. WILSON J. W., SMITH C. E., PLUNKETT O. A. Primary cutaneous coccidioidomycosis; the criteria for diagnosis and a report of a case. Calif Med. 1953 Sep;79(3):233–239. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES